The world’s largest biotechnology company pleaded guilty in federal court today for improper marketing practices involving its anemia drug Aranesp, and says it will pay $762 million in a combination of civil settlements and criminal fines. It won’t lose out on any federal business or contracts, however, which would’ve been a veritable death knell for the company. [More]
amgen
By 2.26.08
../..//2008/02/26/a-new-meta-analysis-showed-that/
A new meta-analysis showed that popular anemia drugs Aranesp and Procrit increase the risk of death in cancer patients by 10 percent, a statistically significant number. [NYT]
